No, there wasn't a checklist. He did verbally mention the manuscrips and analysts are coming....but not much time left in 2016. Unless I missed it, he didn't say anything more on the second clinical trial candidate being confirmed or give a timeline for IND filing. And as we know, no mention of the licensing deal. Perhaps he left off the checklist to avoid reminding the audience that some of these hopeful 2016 milestones may not happen until 2017.

BearDownAZ